Table 2. Main laboratory data, blood gas analysis, ICU scores and noradrenaline dosage of Case 2, over the acute phase.
Case 2 | ED (T=0) | ICU Adm T1 (2 h) | T2 (6 h) | T3 (12 h) | T4 (24 h) | T5 (30 h) | T6 (36 h) | ICU (D) T7 (48 h) |
---|---|---|---|---|---|---|---|---|
Lactate (mmol/L) | >15.5 | >1.5 | >15.5 | 8.3 | 0.9 | 0.6 | 0.6 | 0.8 |
BE (mmol/L) | −23.3 | −25.9 | −21.4 | −1.4 | 2.7 | 8.1 | 1.5 | 9.1 |
PCO2 (mmHg) | 7.2 | 10.5 | 12.1 | 12.1 | 29.5 | 40.5 | 30.1 | 40.6 |
HCO3− (mmol/L) | 2.6 | 2.8 | 5 | 7.1 | 2.7 | 31.7 | 23.9 | 32.6 |
pH | 7.17 | 7.03 | 7.24 | 7.39 | 7.53 | 7.5 | 7.51 | 7.52 |
AG (mEq/L) | 61 | 62 | 55 | 37 | 12 | 4 | 14 | 7 |
Creatinine (mg/dL) | 6.4 | – | – | – | 2.2 | – | – | 1.8 |
Glycemia (mg/dL) | 83 | 87 | 221 | 148 | 146 | 140 | 139 | 162 |
BUN (mg/dL) | 77.5 | – | – | – | 41.1 | – | – | 39.2 |
eGFR (mL/min/1.73 m2) | 7.6 | – | – | – | 27.7 | – | – | 35.3 |
Urine output (mL/kg/ h) | – | – | – | – | 1.13 | >1.2 | >1.2 | >1.2 |
Amylase (U/L) | 37 | – | – | – | – | – | – | – |
INR (ratio) | 1.48 | – | – | – | 1.72 | – | – | 1.63 |
PT (sec) | 17 | – | – | – | 19.7 | – | – | 17.6 |
PTT (sec) | 27 | – | – | – | 32 | – | – | 30 |
PCT (ng/mL) | 0.3 | – | – | – | 0.86 | – | – | 0.85 |
APACHE II score | 28 | – | – | – | 16 | – | – | 13 |
SOFA score | 12 | – | – | – | 7 | – | – | 6 |
Noradrenaline (mcg/kg/min) | 0.35 | – | – | – | – | – | – | – |
Albumin (g/dL) | 2.3 | – | – | – | – | – | – | – |
ICU, intensive care unit; ED, emergency department; Adm, admission; D, discharge; BE, base excess; PCO2, partial pressure of carbon dioxide; AG, anion gap; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; INR, international normalized ratio; PT, prothrombin time; PTT, partial thromboplastin time; PCT, procalcitonin; APACHE, Acute Physiologic Assessment and Chronic Health Evaluation Scoring System; SOFA, Sequential Organ Failure Assessment.